Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: OK..so I'm still in the corner with the delusional group regarding the MOU

A contingency of a material nature must be disclosed per GAAP.

I have not seen such a disclosure in a K or Q, thus such contingency does not exist or is immaterial.

Perhaps we should delude ourselves with something else.

Share
New Message
Please login to post a reply